1 year return (CAGR)
16.90%
Nymox Pharmaceutical Corp Exchange (NASDAQ, USD)
NYMX
-
-0.06 (-11.77%)
HealthcareBiotechnology & Medical Research
Loading...
3 year return (CAGR)
-41.95%
5 year return (CAGR)
-28.99%
10 year return (CAGR)
-24.58%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
42.68M
Price/Sales
-
Ent value
45.69M
Price/Book
-
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-22.03%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 0.51 |
| Daily high | 0.51 |
| Daily low | 0.47 |
| Daily Volume | 9K |
| 1y analyst estimate | 10.25 |
| Beta | 0.65 |
| EPS (TTM) | -0.13 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| NYMX | S&P500 | |
| Current price drop from All-time high | -96.33% | -6.88% |
| Highest price drop | -98.51% | -56.47% |
| Date of highest drop | 30 Jun 2023 | 9 Mar 2009 |
| Avg drop from high | -70.68% | -10.69% |
| Avg time to new high | 720 days | 12 days |
| Max time to new high | 6407 days | 1805 days |
News
No items found